CellCarta adds Tempus to CDx Commercialization Lab Network
Tempus joins as a second commercial laboratory partnership to support oncology-focused access within CellCarta’s CDx Accelerator Model
Tempus joins as a second commercial laboratory partnership to support oncology-focused access within CellCarta’s CDx Accelerator Model
DeepCyte CEO Theodore Alexandrov explains how metabolomics and AI are advancing predictive toxicology, drug safety, and digital cell models
InstaFlux™ enables on-demand enrichment media preparation to streamline food microbiology testing workflows
University of Nottingham uses Genome Detective to replace slower Sanger-based workflows and complex bioinformatics pipelines
Discover how connected data tools can strengthen chromatography oversight and QC decision-making
Restek redefines the benchmark for PFAS testing with 99.8% pure reference standards, long-term batch consistency, and a lab-driven portfolio
Guest editorial from Siemens Healthineers explores how automation, predictive maintenance, connected informatics, and assay innovation can support modern core laboratories
TGCMS-TQ RX Series combines high-sensitivity GC-MS/MS performance with advanced automation and AI-assisted workflows
Small changes to analyzer rules and smarter use of routine CBC parameters can significantly reduce unnecessary smear reviews while maintaining clinically meaningful detection
NanoSomiX and Beckman Coulter Diagnostics collaborate to advance EV-based blood tests for neurodegenerative diseases
Enzyme-based method enables DNA-encoded drug libraries to be built under mild, DNA-friendly conditions
Dr. Nikola Baumann discusses the role of blood-based prognostic testing in improving access for MASLD/MASH patient care
How neurology biomarkers are moving from CSF and PET into accessible blood tests for Alzheimer’s disease and neurodegenerative disease care
New instrument supports advanced materials research and quality control with faster, high-precision analysis
From scalable preclinical workflows to NASA-led investigations, Organ-on-a-Chip technology is demonstrating how New Approach Methodologies can deliver more human-relevant insights